Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
32 hedge funds and large institutions have $9.53M invested in Neurotrope, Inc. Common in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
165% more call options, than puts
Call options by funds: $352K | Put options by funds: $133K
95% more capital invested
Capital invested by funds: $4.9M → $9.53M (+$4.63M)
23% more funds holding
Funds holding: 26 → 32 (+6)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
+$545K |
| 2 |
Renaissance Technologies
New York
|
+$364K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$221K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$198K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
-$108K |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$51.6K |
| 3 |
TCM
Tanaka Capital Management
New York
|
-$28.7K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$27.1K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.02K |
NTRP Hedge Fund Activity: Q1 2019 in Review
32 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q1 2019, worth a combined $9.53M — up 95% from $4.9M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NTRP positions and 1 closed out — a net gain of 6 holders — while 9 added to existing stakes and 8 trimmed.
The largest buyer was MYDA Advisors, opening a new position worth an estimated $545K. The largest seller was Stifel Financial, exiting entirely with an estimated $108K sold.
- 32 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q1 2019, up from 26 in Q4 2018.
- Funds reported $9.53M of Neurotrope, Inc. Common stock for Q1 2019, up 95% quarter-over-quarter.
- 7 funds opened new Neurotrope, Inc. Common positions in Q1 2019 and 1 closed out, a net change of +6 holders.
- The largest Neurotrope, Inc. Common buyer in Q1 2019 was MYDA Advisors, an estimated $545K added.
- The largest Neurotrope, Inc. Common seller in Q1 2019 was Stifel Financial, an estimated $108K sold.
Based on aggregated 13F filings for Q1 2019.